BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 16890450)

  • 41. [Melatonin. Physiology and clinical applications].
    Cardinali DP
    Vertex; 2007; 18(74):288-93. PubMed ID: 18219402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Melatonin, sleep, and circadian rhythm disorders.
    Kayumov L; Zhdanova IV; Shapiro CM
    Semin Clin Neuropsychiatry; 2000 Jan; 5(1):44-55. PubMed ID: 10704537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The basic physiology and pathophysiology of melatonin.
    Claustrat B; Brun J; Chazot G
    Sleep Med Rev; 2005 Feb; 9(1):11-24. PubMed ID: 15649735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin: from biochemistry to therapeutic applications.
    Zawilska JB; Nowak JZ
    Pol J Pharmacol; 1999; 51(1):3-23. PubMed ID: 10389140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).
    Konturek SJ; Konturek PC; Brzozowska I; Pawlik M; Sliwowski Z; Cześnikiewicz-Guzik M; Kwiecień S; Brzozowski T; Bubenik GA; Pawlik WW
    J Physiol Pharmacol; 2007 Sep; 58(3):381-405. PubMed ID: 17928638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sleep Complaints and the 24-h Melatonin Level in Individuals with Smith-Magenis Syndrome: Assessment for Effective Intervention.
    Spruyt K; Braam W; Smits M; Curfs LM
    CNS Neurosci Ther; 2016 Nov; 22(11):928-935. PubMed ID: 27743421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Behavior, sleep and melatonin.
    Lieberman HR
    J Neural Transm Suppl; 1986; 21():233-41. PubMed ID: 3462333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The circadian system in man: From the internal clock to melatonin secretion].
    Touitou Y
    Ann Pharm Fr; 2016 Sep; 74(5):331-4. PubMed ID: 26993958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Melatonin, synthetic analogs, and the sleep/wake rhythm].
    Escames G; Acuña-Castroviejo D
    Rev Neurol; 2009 Mar 1-15; 48(5):245-54. PubMed ID: 19263393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.
    De Leersnyder H; de Blois MC; Vekemans M; Sidi D; Villain E; Kindermans C; Munnich A
    J Med Genet; 2001 Sep; 38(9):586-90. PubMed ID: 11546826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sleep disturbances in Alzheimer's disease and other dementias].
    Vecchierini MF
    Psychol Neuropsychiatr Vieil; 2010 Mar; 8(1):15-23. PubMed ID: 20215095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity.
    Williams SR; Zies D; Mullegama SV; Grotewiel MS; Elsea SH
    Am J Hum Genet; 2012 Jun; 90(6):941-9. PubMed ID: 22578325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circadian rhythm in salivary melatonin in narcoleptic patients.
    Blazejova K; Illnerova H; Hajek I; Nevsimalova S
    Neurosci Lett; 2008 May; 437(2):162-4. PubMed ID: 18436380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Looking for the keys to diurnality downstream from the circadian clock: role of melatonin in a dual-phasing rodent, Octodon degus.
    Vivanco P; Ortiz V; Rol MA; Madrid JA
    J Pineal Res; 2007 Apr; 42(3):280-90. PubMed ID: 17349027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of Sleep Disturbances Associated with Smith-Magenis Syndrome.
    Kaplan KA; Elsea SH; Potocki L
    CNS Drugs; 2020 Jul; 34(7):723-730. PubMed ID: 32495322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sleep disturbance associated with Smith-Magenis syndrome].
    Pan M; Chen L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1262-1265. PubMed ID: 34839521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melatonin, sleep disturbance and cancer risk.
    Blask DE
    Sleep Med Rev; 2009 Aug; 13(4):257-64. PubMed ID: 19095474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic utility of daytime salivary melatonin levels in Smith-Magenis syndrome.
    Chik CL; Rollag MD; Duncan WC; Smith AC
    Am J Med Genet A; 2010 Jan; 152A(1):96-101. PubMed ID: 20034098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sleeping sickness: major disorders of circadian rhythm].
    Buguet A; Bourdon L; Bisser S; Chapotot F; Radomski MW; Dumas M
    Med Trop (Mars); 2001; 61(4-5):328-39. PubMed ID: 11803823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.